Gross profit increased 80.4%
Gross profit changed +80.4% from the comparable as-filed period.
$311,000→$561,0002 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ICU financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income decreased 86.3%
Net income changed -86.3% from the comparable as-filed period.
-$2.0M→-$3.7M3 prior comparisons
Operating income decreased 115.9%
Operating income changed -115.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$1.8M→-$3.8M4 prior comparisons
Operating margin moved 9690 bp lower
Operating margin changed -9690 basis points from the comparable as-filed period.
-519.53%→-616.42%2 prior comparisons
Research & development increased 143.0%
Research & development changed +143.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$1.0M→$2.5M4 prior comparisons
Revenue increased 82.0%
Revenue changed +82.0% from the comparable as-filed period.
$338,000→$615,0002 prior comparisons
Stock-based compensation decreased 202.1%
Stock-based compensation changed -202.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$97,000→-$99,0004 prior comparisons
Gross margin moved 79 bp lower
Gross margin changed -79 basis points from the comparable as-filed period.
92.01%→91.22%2 prior comparisons
Inventory unchangedd 0.0%
Inventory changed +0.0% from the comparable as-filed period.
$77,000→$77,0001 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.